caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578526521

Angelita Palanca-CapistranoM.D.

OphthalmologyCorona, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,521
Unique beneficiaries
—
Total services
2,065
Distinct HCPCS
18
Medicare payment
$165K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,144 Ophthalmology providers in CA — above median (cohort median 1,859).
REFERRAL NETWORK

Where Angelita Palanca-Capistrano's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · West Hills, CA
60201
Glenwood Surgical Center L P
Ambulatory Surgical Center · Riverside, CA
2752
UHS-CORONA INC2147
A'S HOME HEALTH CARE, INC.1921
Md Tox Laboratory
Clinical Laboratory · Irvine, CA
1589
Armando Franco
Family Practice · Moreno Valley, CA
1398
Tarcisio Diaz
Endocrinology · Corona, CA
1262
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,531
Beneficiaries
—
Total drug cost
$241K
Distinct drugs
21
Brand share
22.1%
Top prescribed drugs
Latanoprost684 claims
Prednisolone Acetate333 claims
Dorzolamide Hcl/Timolol Maleat269 claims
Ofloxacin260 claims
Ketorolac Tromethamine239 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
98.1
Cost
72.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$9K
Payment records
47
By payment type
Consulting Fee$6K
Travel and Lodging$1K
Food and Beverage$977
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$638
Education$10